First treatment for peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome

View source ↗

Summary

The EMA approved Emcitate as the first treatment for peripheral thyrotoxicosis in patients with Allan-Herndon-Dudley syndrome, and it can be used in patients of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allan-herndon-dudley Syndrome
• Peripheral Thyrotoxicosis

Drugs mentioned

• Emcitate

Snippet

Emcitate can be used in patients of all ages